151 related articles for article (PubMed ID: 15237576)
1. HER-2/neu receptor in prostate cancer development and progression to androgen independence.
Di Lorenzo G; Autorino R; De Laurentiis M; Cindolo L; D'Armiento M; Bianco AR; De Placido S
Tumori; 2004; 90(2):163-70. PubMed ID: 15237576
[TBL] [Abstract][Full Text] [Related]
2. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ
BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
[TBL] [Abstract][Full Text] [Related]
3. Androgen-dependent regulation of Her-2/neu in prostate cancer cells.
Berger R; Lin DI; Nieto M; Sicinska E; Garraway LA; Adams H; Signoretti S; Hahn WC; Loda M
Cancer Res; 2006 Jun; 66(11):5723-8. PubMed ID: 16740710
[TBL] [Abstract][Full Text] [Related]
4. Her-2-neu expression and progression toward androgen independence in human prostate cancer.
Signoretti S; Montironi R; Manola J; Altimari A; Tam C; Bubley G; Balk S; Thomas G; Kaplan I; Hlatky L; Hahnfeldt P; Kantoff P; Loda M
J Natl Cancer Inst; 2000 Dec; 92(23):1918-25. PubMed ID: 11106683
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between HER-2/neu over-expression and androgen independent prostate cancer].
Bai Q; Chen F; Qi J; Chen JH; Wang YX
Zhonghua Nan Ke Xue; 2007 May; 13(5):414-6. PubMed ID: 17569256
[TBL] [Abstract][Full Text] [Related]
6. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.
Craft N; Shostak Y; Carey M; Sawyers CL
Nat Med; 1999 Mar; 5(3):280-5. PubMed ID: 10086382
[TBL] [Abstract][Full Text] [Related]
7. Involvement of growth factor receptors of the epidermal growth factor receptor family in prostate cancer development and progression to androgen independence.
Lorenzo GD; Bianco R; Tortora G; Ciardiello F
Clin Prostate Cancer; 2003 Jun; 2(1):50-7. PubMed ID: 15046685
[TBL] [Abstract][Full Text] [Related]
8. Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate.
Wang X; Jones TD; Zhang S; Eble JN; Bostwick DG; Qian J; Lopez-Beltran A; Montironi R; Harris JJ; Cheng L
Mod Pathol; 2007 Feb; 20(2):175-82. PubMed ID: 17192792
[TBL] [Abstract][Full Text] [Related]
9. Molecular oncogenesis of prostate adenocarcinoma: role of the human epidermal growth factor receptor 2 (HER-2/neu).
Neto AS; Tobias-Machado M; Wroclawski ML; Fonseca FL; Pompeo AC; Del Giglio A
Tumori; 2010; 96(5):645-9. PubMed ID: 21302606
[TBL] [Abstract][Full Text] [Related]
10. Her-2/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease.
Shi Y; Brands FH; Chatterjee S; Feng AC; Groshen S; Schewe J; Lieskovsky G; Cote RJ
J Urol; 2001 Oct; 166(4):1514-9. PubMed ID: 11547123
[TBL] [Abstract][Full Text] [Related]
11. [Androgen-independent prostate carcinoma and androgen-receptor: recent progress in molecular genetics].
Sultan C; Terouanne B; Tahiri B; Lumbroso S; Avances C; Orio F
Bull Cancer; 1999; 86(7-8):618-21. PubMed ID: 10477378
[TBL] [Abstract][Full Text] [Related]
12. Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells.
Dahl M; Bouchelouche P; Kramer-Marek G; Capala J; Nordling J; Bouchelouche K
Mol Biol Rep; 2011 Oct; 38(7):4237-43. PubMed ID: 21755295
[TBL] [Abstract][Full Text] [Related]
13. Update on HER-kinase-directed therapy in prostate cancer.
Gross ME; Jo S; Agus DB
Clin Adv Hematol Oncol; 2004 Jan; 2(1):53-6, 64. PubMed ID: 16163160
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer.
Liu Y; Majumder S; McCall W; Sartor CI; Mohler JL; Gregory CW; Earp HS; Whang YE
Cancer Res; 2005 Apr; 65(8):3404-9. PubMed ID: 15833875
[TBL] [Abstract][Full Text] [Related]
15. Expression of HER2/NEU in newly diagnosed metastatic carcinoma prostate on TRUS biopsy specimen and its clinical correlation and progression.
Abhishek A; Sarkar D; Kumar Pal D
Urologia; 2023 May; 90(2):244-247. PubMed ID: 36000702
[TBL] [Abstract][Full Text] [Related]
16. The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.
Brizzolara A; Benelli R; Venè R; Barboro P; Poggi A; Tosetti F; Ferrari N
Cancer Lett; 2017 Aug; 400():9-17. PubMed ID: 28450158
[TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.
Di Lorenzo G; Tortora G; D'Armiento FP; De Rosa G; Staibano S; Autorino R; D'Armiento M; De Laurentiis M; De Placido S; Catalano G; Bianco AR; Ciardiello F
Clin Cancer Res; 2002 Nov; 8(11):3438-44. PubMed ID: 12429632
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
Singh AP; Bafna S; Chaudhary K; Venkatraman G; Smith L; Eudy JD; Johansson SL; Lin MF; Batra SK
Cancer Lett; 2008 Jan; 259(1):28-38. PubMed ID: 17977648
[TBL] [Abstract][Full Text] [Related]
19. Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824.
Chen L; Meng S; Wang H; Bali P; Bai W; Li B; Atadja P; Bhalla KN; Wu J
Mol Cancer Ther; 2005 Sep; 4(9):1311-9. PubMed ID: 16170022
[TBL] [Abstract][Full Text] [Related]
20. Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models.
Agus DB; Scher HI; Higgins B; Fox WD; Heller G; Fazzari M; Cordon-Cardo C; Golde DW
Cancer Res; 1999 Oct; 59(19):4761-4. PubMed ID: 10519379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
